Author:
You Amy S.,Kalantar Sara S.,Norris Keith C.,Peralta Rene Amel,Narasaki Yoko,Fischman Ronald,Fischman Michael,Semerjian Avedik,Nakata Tracy,Azadbadi Zahra,Nguyen Danh V.,Kalantar-Zadeh Kamyar,Rhee Connie M.
Abstract
Abstract
Background
Dialysis patients experience a high symptom burden, which may adversely impact their quality of life. Whereas other specialties emphasize routine symptom assessment, symptom burden is not well-characterized in dialysis patients. We sought to examine the prevalence and severity of unpleasant symptoms in a prospective hemodialysis cohort.
Methods
Among 122 hemodialysis patients from the prospective Malnutrition, Diet, and Racial Disparities in Chronic Kidney Disease (CKD) study, CKD-associated symptoms were ascertained by the Dialysis Symptom Index, a validated survey assessing symptom burden/severity (with higher scores indicating greater symptom severity), over 6/2020–10/2020. We examined the presence of (1) individual symptoms and symptom severity scores, and (2) symptom clusters (defined as ≥ 2 related concurrent symptoms), as well as correlations with clinical characteristics.
Results
Symptom severity scores were higher among non-Hispanic White and Hispanic patients, whereas scores were lower in Black and Asian/Pacific Islander patients. In the overall cohort, the most common individual symptoms included feeling tired/lack of energy (71.3%), dry skin (61.5%), trouble falling asleep (44.3%), muscle cramps (42.6%), and itching (42.6%), with similar patterns observed across racial/ethnic groups. The most prevalent symptom clusters included feeling tired/lack of energy + trouble falling asleep (37.7%); trouble falling asleep + trouble staying asleep (34.4%); and feeling tired/lack of energy + trouble staying asleep (32.0%). Lower hemoglobin, iron stores, and dialysis adequacy correlated with higher individual and overall symptom severity scores.
Conclusion
We observed a high prevalence of unpleasant symptoms and symptom clusters in a diverse hemodialysis cohort. Further studies are needed to identify targeted therapies that ameliorate symptom burden in CKD.
Graphical abstract
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Kalantar-Zadeh K, Lockwood MB, Rhee CM, Tantisattamo E, Andreoli S, Balducci A et al (2022) Patient-centered approaches for the management of unpleasant symptoms in kidney disease. Nature Rev Nephrol 2022:1–4
2. Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO (2017) Symptom management of the patient with CKD: the role of dialysis. Clin J Am Soc Nephrol 12(4):687–693
3. Kalantar-Zadeh K, Wightman A, Liao S (2020) Ensuring choice for people with kidney failure—dialysis, supportive care, and hope. N Engl J Med 383(2):99
4. Rhee CM, Nguyen DV, Nyamathi A, Kalantar-Zadeh K (2020) Conservative vs preservative management of chronic kidney disease: similarities and distinctions. Curr Opin Nephrol Hypertens 29(1):92–102
5. Zarantonello D, Rhee CM, Kalantar-Zadeh K, Brunori G (2021) Novel conservative management of chronic kidney disease via dialysis-free interventions. Curr Opin Nephrol Hypertens 30(1):97–107
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献